Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Esperion Theraptc (ESPR)

Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 447,126
  • Shares Outstanding, K 189,460
  • Annual Sales, $ 116,330 K
  • Annual Income, $ -209,250 K
  • 60-Month Beta 1.02
  • Price/Sales 3.81
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ESPR with:

Options Overview Details

View History
  • Implied Volatility 54.74% ( -44.40%)
  • Historical Volatility 84.79%
  • IV Percentile 1%
  • IV Rank 5.74%
  • IV High 280.67% on 07/24/23
  • IV Low 40.97% on 06/13/24
  • Put/Call Vol Ratio 0.22
  • Today's Volume 401
  • Volume Avg (30-Day) 3,460
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 98,209
  • Open Int (30-Day) 106,872

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.16
  • Number of Estimates 6
  • High Estimate -0.01
  • Low Estimate -0.25
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +65.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.05 +15.12%
on 06/28/24
3.12 -24.36%
on 06/10/24
+0.12 (+5.36%)
since 06/03/24
3-Month
1.71 +38.01%
on 04/19/24
3.40 -30.59%
on 04/08/24
-0.76 (-24.36%)
since 04/03/24
52-Week
0.70 +237.14%
on 10/12/23
3.40 -30.59%
on 04/08/24
+0.94 (+66.20%)
since 07/03/23

Most Recent Stories

More News
Stocks Climb Before the Open as Investors Await U.S. Economic Data, BoE Decision in Focus

June S&P 500 E-Mini futures (ESM24) are up +0.37%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.62% this morning as trading resumed after the Juneteenth holiday, with investors looking ahead to...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
NVDA : 128.28 (+4.57%)
MU : 136.82 (+3.19%)
SILK : 27.00 (-0.07%)
LEN : 143.28 (-0.23%)
ACN : 305.75 (+0.63%)
KR : 50.75 (+0.63%)
DRI : 145.42 (-0.92%)
JBL : 110.10 (+1.45%)
WGO : 53.26 (-0.34%)
ASM.NA : 720.400 (+2.45%)
Esperion Therapeutics: Q1 Earnings Snapshot

Esperion Therapeutics: Q1 Earnings Snapshot

ESPR : 2.36 (+0.85%)
Esperion Therapeutics: Q4 Earnings Snapshot

Esperion Therapeutics: Q4 Earnings Snapshot

ESPR : 2.36 (+0.85%)
Esperion Therapeutics: Q3 Earnings Snapshot

Esperion Therapeutics: Q3 Earnings Snapshot

ESPR : 2.36 (+0.85%)
Esperion Therapeutics: Q2 Earnings Snapshot

Esperion Therapeutics: Q2 Earnings Snapshot

ESPR : 2.36 (+0.85%)
Esperion Therapeutics: Q1 Earnings Snapshot

Esperion Therapeutics: Q1 Earnings Snapshot

ESPR : 2.36 (+0.85%)
Stock Index Futures Mixed as Bank Jitters Weigh on Sentiment, ECB Decision in Focus

March S&P 500 futures (ESH23) are down -0.10%, and March Nasdaq 100 E-Mini futures (NQH23) are up +0.21% this morning after three major U.S. benchmark indices ended the regular session mixed as signs of...

ESH23 : 3,957.05s (-0.09%)
NQU24 : 20,381.25 (-0.15%)
CS : 0.8858 (+0.99%)
META : 509.96 (+0.09%)
AMZN : 197.59 (-1.21%)
MSFT : 460.77 (+0.32%)
ADBE : 570.15 (+0.43%)
PATH : 12.96 (unch)
LPSN : 0.6149 (+6.85%)
ESPR : 2.36 (+0.85%)
CVI : 26.58 (+1.41%)
ENVX : 15.28 (+7.68%)
Stocks Set To Open Mixed As Investors Await Powell Testimony

March S&P 500 futures (ESH23) are down -0.11%, and March Nasdaq 100 E-Mini futures (NQH23) are up +0.02% this morning as market participants awaited testimony from Federal Reserve Chair Jerome Powell and...

ESH23 : 3,957.05s (-0.09%)
NQU24 : 20,381.25 (-0.15%)
TIT.M.DX : 0.236 (+1.72%)
EURN : 16.82 (+0.12%)
ESPR : 2.36 (+0.85%)
AAPL : 221.55 (+0.58%)
PRGO : 26.19 (+0.77%)
NXT : 47.37 (+4.52%)
Esperion Therapeutics: Q4 Earnings Snapshot

Esperion Therapeutics: Q4 Earnings Snapshot

ESPR : 2.36 (+0.85%)
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ANN ARBOR, Mich., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that, on August 2, 2022, the Compensation Committee of...

ESPR : 2.36 (+0.85%)

Business Summary

Esperion Therapeutics, Inc. is a pharmaceutical company focused on the development of oral lipid-management treatments for cardiovascular diseases caused by elevated levels of LDL-C (bad cholesterol).

See More

Key Turning Points

3rd Resistance Point 2.49
2nd Resistance Point 2.45
1st Resistance Point 2.40
Last Price 2.36
1st Support Level 2.32
2nd Support Level 2.28
3rd Support Level 2.23

See More

52-Week High 3.40
Fibonacci 61.8% 2.37
Last Price 2.36
Fibonacci 50% 2.05
Fibonacci 38.2% 1.73
52-Week Low 0.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar